TABLE 2.

Location of injury in glomerulonephritis.

Location	Disease
Mesangial cell	IgA nephropathy
	Mesangioproliferative glomerulonephritis
	Class II lupus nephritis
	Diabetic nephropathy
Endothelial cell	Infection associated glomerulonephritis
	Membranoproliferative glomerulonephritis
	Class III and IV lupus nephritis
	Anti GBM disease
	Hemolytic uremic syndrome
	Vasculitis
Epithelial cell	Membranous nephropathy
	Minimal change nephropathy
	focal segmental glomerulosclerosis
	Class IV lupus nephritis

Table of Contents: Kidney disease has become a global health problem. And with nanotechnology, therapeutic agents can achieve selective accumulation at the kidney, and thus reduce the side effect and increase drug concentration on the diseased site. Here we summarized recent advances in nanoparticles designed for kidney targeted delivery according to the targeting sites.